249
Views
29
CrossRef citations to date
0
Altmetric
Original Article: Research

Assessment of carbonic anhydrase IX expression and extracellular pH in B-cell lymphoma cell line models

, , , , , & show all
Pages 1432-1439 | Received 31 Mar 2014, Accepted 05 Jun 2014, Published online: 10 Nov 2014

References

  • Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013;63:11–30.
  • Calvo-Vidal MN, Cerchietti L. The metabolism of lymphomas. Curr Opin Hematol 2013;20:345–354.
  • Chiche J, Brahimi-Horn MC, Pouyssegur J. Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer. J Cell Mol Med 2010;14:771–794.
  • Hill RP, De JK, Jang A, et al. pH, hypoxia and metastasis. Novartis Found Symp 2001;240:154–165.
  • DeClerck K, Elble RC. The role of hypoxia and acidosis in promoting metastasis and resistance to chemotherapy. Front Biosci 2010;15:213–225.
  • Chiche J, Ilc K, Laferriere J, et al. Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH. Cancer Res 2009;69:358–368.
  • Pastorek J, Pastorekova S, Callebaut I, et al. Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. Oncogene 1994;9:2877–2888.
  • Becker HM, Klier M, Deitmer JW. Carbonic anhydrases and their interplay with acid/base-coupled membrane transporters. Subcell Biochem 2014;75:105–134.
  • Chen LQ, Howison CM, Jeffery JJ, et al. Evaluations of extracellular pH within in vivo tumors using acidoCEST MRI. Magn Reson Med 2013 Nov 26. [Epub ahead of print]
  • Kaluz S, Kaluzova M, Liao SY, et al. Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: a one transcription factor (HIF-1) show? Biochim Biophys Acta 2009;1795:162–172.
  • van Den BT, Koritzinsky M, Niessen H, et al. Hypoxia-induced expression of carbonic anhydrase 9 is dependent on the unfolded protein response. J Biol Chem 2009;284:24204–24212.
  • Potter CP, Harris AL. Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer. Br J Cancer 2003; 89:2–7.
  • Gillies RJ, Gatenby RA. Hypoxia and adaptive landscapes in the evolution of carcinogenesis. Cancer Metastasis Rev 2007;26:311–317.
  • Sedlakova O, Svastova E, Takacova M, et al. Carbonic anhydrase IX, a hypoxia-induced catalytic component of the pH regulatory machinery in tumors. Front Physiol 2014;3:400.
  • Sawada H, Taniguchi K, Takami K. Improved toxicogenomic screening for drug-induced phospholipidosis using a multiplexed quantitative gene expression ArrayPlate assay. Toxicol In Vitro 2006; 20:1506–1513.
  • Rasband WS. ImageJ, US National Institutes of Health, Bethesda, Maryland, USA. 1997–2012. Available from: http://imagej.nih.gov/ij/
  • Sheth VR, Liu G, Li Y, et al. Improved pH measurements with a single PARACEST MRI contrast agent. Contrast Media Mol Imaging 2012;7:26–34.
  • De Saedeleer CJ, Copetti T, Porporato PE, et al. Lactate activates HIF-1 in oxidative but not in Warburg-phenotype human tumor cells. PLoS One 2012;7:e46571.
  • Liu G, Li Y, Sheth VR, et al. Imaging in vivo extracellular pH with a single paramagnetic chemical exchange saturation transfer magnetic resonance imaging contrast agent. Mol Imaging 2012; 11:47–57.
  • Stewart M, Talks K, Leek R, et al. Expression of angiogenic factors and hypoxia inducible factors HIF 1, HIF 2 and CA IX in non-Hodgkin's lymphoma. Histopathology 2002;40:253–260.
  • Badari AR, Abu Zaid M, Unger JM, et al. Markers of angiogenesis and hypoxia to cell of origin (COO) subtypes of DLBCL: correlative studies from S 0515, a phase II trial of R-CHOP plus bevacizumab. J Clin Oncol 2013; 31(Suppl.): Abstract 8562.
  • Powell JR, Dojcinov S, King L, et al. Prognostic significance of hypoxia inducible factor-1alpha and vascular endothelial growth factor expression in patients with diffuse large B-cell lymphoma treated with rituximab. Leuk Lymphoma 2013;54:959–966.
  • Argyriou P, Papageorgiou SG, Panteleon V, et al. Hypoxia-inducible factors in mantle cell lymphoma: implication for an activated mTORC1> HIF-1alpha pathway. Ann Hematol 2011;90:315–322.
  • McDonald PC, Winum JY, Supuran CT, et al. Recent developments in targeting carbonic anhydrase IX for cancer therapeutics. Oncotarget 2012;3:84–97.
  • Suthar SK, Bansal S, Lohan S, et al. Design and synthesis of novel 4-(4-oxo-2-arylthiazolidin-3-yl)benzenesulfonamides as selective inhibitors of carbonic anhydrase IX over I and II with potential anticancer activity. Eur J Med Chem 2013;66:372–379.
  • Bertout JA, Patel SA, Simon MC. The impact of O2 availability on human cancer. Nat Rev Cancer 2008;8:967–975.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.